Drug Guide

Generic Name

Mestranol and Norethynodrel

Brand Names Enovid, Enovid-e, Enovid-e 21

Classification

Therapeutic: Contraceptive, hormone hormone combination

Pharmacological: Estrogen and progestin combination

FDA Approved Indications

  • Oral contraception

Mechanism of Action

Mestranol is a prodrug of ethinylestradiol (estrogen), which suppresses ovulation by feedback inhibition of the hypothalamus and pituitary, reducing gonadotropin release. Norethynodrel is a progestin that also suppresses ovulation, alters cervical mucus making it less penetrable to sperm, and changes the endometrial lining to prevent implantation.

Dosage and Administration

Adult: Typically, one tablet daily for 21 or 28 days as directed by the physician.

Pediatric: Not indicated for pediatric use.

Geriatric: Not specifically indicated for geriatric population.

Renal Impairment: Adjustments not well established; use with caution.

Hepatic Impairment: Use is contraindicated or caution advised due to hepatic metabolism.

Pharmacokinetics

Absorption: Well absorbed from gastrointestinal tract.

Distribution: Plasma protein binding varies by component.

Metabolism: Extensively metabolized in the liver via conjugation and hydroxylation.

Excretion: Excreted primarily in urine and feces.

Half Life: Mestranol has a half-life of approximately 2-4 hours, norethynodrel approximately 24 hours.

Contraindications

  • History of thromboembolic disorders
  • Estrogen-dependent neoplasia
  • Abnormal vaginal bleeding of unknown cause
  • Pregnancy

Precautions

  • History of migraines, smoking, liver disease, hypertension, diabetes, or gallbladder disease.

Adverse Reactions - Common

  • Nausea or vomiting (Common)
  • Breast tenderness (Common)
  • Headache (Common)
  • Weight gain (Less common)

Adverse Reactions - Serious

  • Deep vein thrombosis (DVT) (Serious/perhaps rare)
  • Myocardial infarction (Serious)
  • Stroke (Serious)
  • Hypertension (Less common)
  • Liver tumors (Rare)

Drug-Drug Interactions

  • Antibiotics such as penicillins, tetracyclines which may reduce contraceptive effectiveness
  • Anticonvulsants like phenytoin, phenobarbital, carbamazepine

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Assess for contraindications, pregnancy status, and compliance.

Diagnoses:

  • Risk for ineffective contraception
  • Risk for thrombosis

Implementation: Advise patient to take medication at the same time daily, preferably with food to reduce gastrointestinal upset.

Evaluation: Monitor for signs of pregnancy or adverse effects; assess compliance regularly.

Patient/Family Teaching

  • Instruct on proper use, missed dose instructions, and importance of daily intake.
  • Warn about side effects, especially signs of thromboembolic events.
  • Advise on using additional contraceptive methods if gastrointestinal disturbances occur.

Special Considerations

Black Box Warnings:

  • Increased risk of blood clots, stroke, and myocardial infarction, especially in women over 35 who smoke.

Genetic Factors: Genetic variations may influence drug metabolism.

Lab Test Interference: May affect hepatic function tests, coagulation studies, or lipid profiles.

Overdose Management

Signs/Symptoms: Nausea, vomiting, dizziness, or unexpected vaginal bleeding.

Treatment: Supportive care, symptomatic treatment, and gastric lavage if ingestion was recent.

Storage and Handling

Storage: Store at room temperature, away from heat and moisture.

Stability: Stable when stored properly for the duration of labeled shelf life.

This guide is for educational purposes only and is not intended for clinical use.